GNH USA

Europe — EMA

Metopirone

GNH USA supplies Metopirone (Metyrapone), a 11‑beta‑hydroxylase inhibitor for adrenal insufficiency testing and Cushing's syndrome. Request a quote.

Metyrapone

Request sourcing

1
Pack/s

What is Metyrapone?

Metyrapone, the active ingredient in Metopirone, is a 11‑beta‑hydroxylase inhibitor presented as an oral tablet for oral use. It is used in the diagnostic testing of adrenal insufficiency and in the treatment of Cushing's syndrome in adults.

GNH USA supplies Metopirone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Metyrapone used for?

Metopirone (metyrapone) is employed in endocrine diagnostics and therapy related to cortisol production.

- Adrenal insufficiency (diagnostic testing): helps assess adrenal reserve by stimulating ACTH response. - Cushing's syndrome (treatment): reduces cortisol synthesis in patients with endogenous hypercortisolism. - ACTH stimulation test (diagnostic): used to evaluate pituitary‑adrenal axis function.

What are the side effects of Metyrapone?

Metyrapone may cause a range of adverse reactions, some of which are common and others that are serious or rare.

Common Side Effects: - Nausea - Dizziness - Headache - Fatigue

Serious or Rare Side Effects: - Adrenal insufficiency - Severe hypotension - Allergic reaction (e.g., rash, angioedema)

What precautions apply to Metyrapone?

When using Metopirone, several safety considerations should be observed.

- Monitor cortisol levels: regular testing to avoid adrenal crisis. - Assess electrolyte balance: watch for hyponatremia and potassium shifts. - Avoid abrupt discontinuation: taper under medical supervision. - Use caution in hepatic impairment: adjust monitoring. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

What does Metyrapone interact with?

Metyrapone can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Ketoconazole: additive inhibition of cortisol synthesis may cause severe adrenal suppression. - Mifepristone: opposing effects on glucocorticoid pathways may reduce efficacy.

Moderate Interactions (Monitor Closely): - Carbamazepine: enzyme induction may reduce metyrapone levels. - Rifampin: may increase metabolism, lowering effect. - Oral contraceptives: may alter hormone levels, monitor closely.

Frequently asked questions

What is Metopirone used for?+
Metopirone (metyrapone) is used primarily for diagnostic testing of adrenal insufficiency and for the treatment of Cushing's syndrome. It helps evaluate adrenal function and reduces cortisol production in patients with excess cortisol.
How does Metyrapone work?+
Metyrapone inhibits the adrenal enzyme 11‑beta‑hydroxylase, which is essential for the final step of cortisol synthesis. By blocking this enzyme, the drug lowers cortisol levels and triggers a rise in ACTH, useful for both diagnostic and therapeutic purposes.
What is the usual dose of Metopirone?+
The dosage of Metopirone is individualized. A qualified prescriber determines the appropriate dose based on the specific indication, patient characteristics, and clinical response. Patients should follow the prescribing information provided by their healthcare professional.
Is Metopirone safe in pregnancy or breastfeeding?+
The pregnancy category for metyrapone is unknown. It should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. Consultation with a healthcare provider is essential.
How do I order Metopirone from GNH USA?+
To order Metopirone, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Metopirone compare with other cortisol‑lowering drugs?+
Metopirone differs from alternatives such as ketoconazole or osilodrostat by specifically targeting 11‑beta‑hydroxylase. Ketoconazole has broader enzyme inhibition and may cause more hepatic effects, while osilodrostat also inhibits 11‑beta‑hydroxylase but with a different potency and safety profile. Choice depends on clinical context and physician judgment.
What are the storage and handling requirements for Metopirone?+
Metopirone tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect them from moisture, excessive heat and direct sunlight to maintain stability and potency.
How is Metopirone administered?+
Metopirone is taken orally, usually with a glass of water. The exact timing (e.g., with or without food) and frequency are determined by the prescribing clinician based on the therapeutic goal.
What are the most serious risks associated with Metopirone?+
The most serious risks include adrenal insufficiency, which can lead to life‑threatening hypotension, severe hypotension itself, and allergic reactions such as rash or angioedema. Patients should be monitored closely for these events.
Who should not use Metopirone?+
Metopirone should be avoided in individuals with known hypersensitivity to metyrapone or any excipients, and in patients with severe hepatic impairment unless specifically directed by a specialist. Caution is also advised for those with uncontrolled cardiovascular disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Metyrapone
Route
Oral Use
Manufacturer
Hra Pharma Rare Diseases
Origin
EU

Related products